<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA Internal Medicine: Swallowing/Dysphagia Topic Collection</title>
    <link>http://archinte.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Wed, 26 Dec 2012 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 01 Jan 2013 00:52:30 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@archinte.jamanetwork.com</managingEditor>
    <webMaster>webmaster@archinte.jamanetwork.com</webMaster>
    <item>
      <title>Correcting Several Oversimplifications of Chronic Opioid Therapy</title>
      <link>http://archinte.jamanetwork.com/article.aspx?articleID=487005</link>
      <pubDate>Mon, 28 Mar 2011 00:00:00 GMT</pubDate>
      <author>Geller AS. </author>
      <description>&lt;span class="paragraphSection"&gt;Braden et al appropriately reported chronic opioid therapy risk stratification with prescription minimization recommendations but erroneously oversimplified hazard attribution to “high-potency” schedule II opioids and the generic term &lt;span style="font-style:italic;"&gt;schedule II long-acting opioids&lt;/span&gt;.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">171</prism:volume>
      <prism:number xmlns:prism="prism">6</prism:number>
      <prism:startingPage xmlns:prism="prism">597</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">597</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/archinternmed.2011.84</prism:doi>
      <guid>http://archinte.jamanetwork.com/article.aspx?articleID=487005</guid>
    </item>
  </channel>
</rss>